Prediction of Intrafraction Prostate Motion: Accuracy of Pre- and Post-Treatment Imaging and Intermittent Imaging

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 3, 2009, Pages 692-698

  Noel, Camille ^a   Parikh, Parag J ^a   Roy, Meghana ^a   Kupelian, Patrick ^b   Mahadevan, Arul ^c   Weinstein, Geoffrey ^d   Enke, Charles ^e   Flores, Nicholas ^f   Beyer, David ^e   Levine, Lisa ^g  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b M D ANDERSON CANCER CENTER ORLANDO   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d SHARP MEMORIAL HOSPITAL   (United States)

^e NEBRASKA MEDICAL CENTER   (United States)

^f Arizona Oncology Services   (United States)

^g Calypso Medical Technologies   (United States)

Author keywords

Organ motion; Prostate cancer; Radiation therapy; Target localization; Tracking

Indexed keywords

RADIOTHERAPY;

ORGAN MOTION; PROSTATE CANCER; RADIATION THERAPY; TARGET LOCALIZATION; TRACKING;

RADIATION;

ACCURACY; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; HEALTH CARE DELIVERY; HUMAN; IMAGING; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; SAMPLING; SENSITIVITY AND SPECIFICITY; THERAPY EFFECT;

ELECTROMAGNETIC FIELDS; HUMANS; MALE; MOVEMENT; PROSTATE; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 59649124228     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.076     Document Type: Article

References (33)

1. Cheung R., Tucker S.L., Dong L., et al. Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 1234-1240
2. Kupelian P.A., Mohan D.S., Lyons J., et al. Higher than standard radiation doses (≥72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 46 (2000) 567-574
3. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
4. Kupelian P.A., Potters L., Khuntia D., et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 25-33
5. Pollack A., Hanlon A.L., Horwitz E.M., et al. Prostate cancer radiotherapy dose response: An update of the Fox Chase experience. J Urol 171 (2004) 1132-1136
6. Hanks G.E., Hanlon A.L., Epstein B., et al. Dose response in prostate cancer with 8-12 years' follow-up. Int J Radiat Oncol Biol Phys 54 (2002) 427-435
7. Kuban D., Pollack A., Huang E., et al. Hazards of dose escalation in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 1260-1268
8. Speight J.L., and Roach M. Radiotherapy in the management of clinically localized prostate cancer: Evolving standards, consensus, controversies, and new directions. J Clin Oncol 23 (2005) 8176-8185
9. Lock M., and Catton C. High-precision radiotherapy: Where are we going and how do we get there?. Can J Urol 13 Suppl (2006) 34-36
10. Aubry J.F., Beaulieu L., Girouard L.M., et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys 60 (2004) 30-39
11. Kitamura K., Shirato H., Seppenwoolde Y., et al. Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys 53 (2002) 1117-1123
12. Nederveen A.J., van der Heide U.A., Dehnad H., et al. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys 53 (2002) 206-214
13. Trichter F., and Ennis R.D. Prostate localization using transabdominal ultrasound imaging. Int J Radiat Oncol Biol Phys 56 (2003) 1225-1233
14. Willoughby T.R., Kupelian A., Pouliot J., et al. Target localization and real-time tracking using the Calypso 4D Localization System in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 65 (2006) 528-534
15. Litzenberg D.W., Balter J.M., Hadley S.W., et al. Influence of intrafraction motion on margins for prostate brachytherapy. Int J Radiat Oncol Biol Phys 65 (2006) 548-553
16. De Crevoisier R., Melancon A.D., Kuban D.A., et al. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 1529-1536
17. Kupelian P., Willoughby T., Mahadevan A., et al. Multi-institutional clinical experience with the Calypso System in localization and continuous real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1088-1098
18. Kotte A.N., Hofman P., Lagendijk J.J., et al. Intrafraction motion of the prostate during external-beam radiation therapy: Analysis of 427 patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys 69 (2007) 419-425
19. Huang E., Dong L., Chandra A., et al. Intrafraction prostate motion during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 261-268
20. Cheung P., Sixel K., Morton G., et al. Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer. Int J Radiat Oncol Biol Phys 62 (2005) 418-425
21. Soete G., De Cock M., Verellen D., et al. X-ray-assisted positioning of patients treated by conformal ARC radiotherapy for prostate cancer: Comparison of setup accuracy using implanted markers versus bony structures. Int J Radiat Oncol Biol Phys 67 (2007) 823-827
22. Létourneau D., Martinez A.A., Lockman D., et al. Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients. Int J Radiat Oncol Biol Phys 62 (2005) 1239-1246
23. Padhani A.R., Khoo V.S., Suckling J., et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys 44 (1999) 525-533
24. Mah D., Freedman G., Milestone B., et al. Measurement of intrafractional prostate motion using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 54 (2002) 568-575
25. Ghilezan M.J., Jaffray D.A., Siewerdsen J.H., et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 62 (2005) 406-417
26. Britton K.R., Takai Y., Mitsuya M., Nemoto K., Ogawa Y., and Yamada S. Evaluation of inter- and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer by a newly developed on-board image-guided system. Radiat Med 23 (2005) 14-24
27. Balter J.M., Wright J.N., Newell L.J., et al. Accuracy of a wireless localization system for radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 933-937
28. Litzenberg D.W., Willoughby T.R., Balter J.M., et al. Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking. Int J Radiat Oncol Biol Phys 68 (2007) 1199-1206
29. Raaijmakers A.J., Raaymakers B.W., van der Meer S., and Lagendijk J.J. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: Impact of the surface orientation on the entrance and exit dose due to the transverse magnetic field. Phys Med Biol 52 (2007) 929-939
30. Soete G., Arcangeli S., De Meerleer G., et al. Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: Report on acute toxicity. Radiother Oncol 80 (2006) 78-81
31. Koukourakis M.I., Touloupidis S., Manavis J., Abatzoglou I., Sismanidou K., and Sivridis L. Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: Rationale, technique and early experience. Anticancer Res 24 (2004) 3239-3243
32. Madsen B.L., His R.A., Pham H.T., et al. Intrafractional stability of the prostate using a stereotactic radiotherapy technique. Int J Radiat Oncol Biol Phys 57 (2003) 1285-1291
33. Madsen B.L., His R.A., Pham H.T., et al. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results. Int J Radiat Oncol Biol Phys 67 (2007) 1099-1105